Romano Brothers & Co’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AIM
FWIA
DLA
SLAM
Romano Brothers & Co's BMY Position: Q2 2026 in Review
Romano Brothers & Co reduced its Bristol-Myers Squibb (BMY) stake by 28% in Q2 2026, selling an estimated $1.02M and leaving 46,486 shares worth $2.68M. The position accounts for 0.27% of the portfolio, ranked #92.
Romano Brothers & Co first reported a position in BMY in Q3 2022 and has held it in 16 quarters since. The position peaked at $8.51M in Q4 2022. 1,031 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Romano Brothers & Co held 46,486 shares of Bristol-Myers Squibb worth $2.68M as of Q2 2026.
- Romano Brothers & Co sold 17,814 Bristol-Myers Squibb shares in Q2 2026, an estimated $1.02M.
- Bristol-Myers Squibb made up 0.27% of Romano Brothers & Co's portfolio in Q2 2026, its #92 holding.
- Romano Brothers & Co first reported a position in Bristol-Myers Squibb in Q3 2022 and has held it in 16 quarters since.
- Romano Brothers & Co's Bristol-Myers Squibb position peaked at $8.51M in Q4 2022.
- 1,031 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Romano Brothers & Co's 13F filing for Q2 2026, filed 22 Jul 2026.